FISCHER share price & delivery % — Fischer Medical Ventures

Filings & corporate actions

5 results filed

CSV

Next results · Q2 FY27

Expected 29 Oct 2026 – 30 Nov 2026

Estimate: filed 29–61 days after quarter end, last 5 times

Dividend

₹0.05 per share · last 22 Sept 2026

2026

22 SeptdividendDividend · ₹0.05 per share+0.2%
21 AugshareholdingShareholding · 17 Aug 2026-2.1%NSE
14 AugresultsResults · Q1 FY27 · consolidated and standalone-3.5%NSE
18 JulshareholdingShareholding · 30 Jun 2026+1.7%NSE
31 MayresultsResults · Q4 FY26 · consolidated and standalone-5.0%NSE
17 AprshareholdingShareholding · 31 Mar 2026+0.6%NSE
30 JanresultsResults · Q3 FY26 · consolidated and standalone-2.5%NSE
14 JanshareholdingShareholding · 31 Dec 2025-2.5%NSE

Reaction to results · all yearsrose on day 0 in 2 of 5 CSV

Quarter	Filed	Day 0	+5D	+20D	Rel vol
Q1 FY27	14 Aug 2026	-3.5%	-5.6%	-12.0%	0.3×
Q4 FY26	31 May 2026	-5.0%	-15.3%	+9.4%	0.1×
Q3 FY26	30 Jan 2026	-2.5%	+14.6%	-0.6%	1.2×
Q2 FY26	29 Oct 2025	+5.7%	-11.5%	-57.9%	22.2×
Q1 FY26	14 Aug 2025	+1.0%	+7.6%	+13.9%	0.3×
Average		-0.9%	-2.0%	-9.4%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV

Revenue YoY+249.4%

Profit YoY-24.3%

Interest cost YoY—

Revenue QoQ-16.2%

Profit QoQ—

CAGR	2Y	3Y	4Y	5Y	6Y	7Y
Revenue	—	—	—	—	—	—
Profit	—	—	—	—	—	—

Key data

CSV

Open33.00

Day range32.41 – 33.39

52-week range31.05 – 121.70

From 52w high-72.8%

RSI (14)39.8

ATR (14)1.73

Volume1.70L

Avg volume (20D)10.10L

Rel volume0.17×

Volatility (1Y)54.9%

Turnover₹56.3L

SMA 50 / 20036.12 / 37.75

Delivery percentage

Latest · 6 Oct 202656.2%

20-day avg58.2%

1-year avg41.1%

Percentile (own history)80th

Range3.6–100.0%

Sessions307

Over the last 20 sessions FISCHER settled 58.2% of its traded quantity, which is above average for an NSE equity. Its one-year average is 41.1%, so recent sessions are running 17.1 points higher than usual. The latest session ranks higher than 80% of the 307 sessions on record for it.

What delivery percentage measures Scan the whole market on delivery

IndustryMedical Equipment & Supplies

PeersMOLBIO POLYMED TARSONS LAXMIDENTL FABTECH GKB

Performance returns

CSV

	1D	1W	1M	3M	6M	1Y
Price	+1.04%	-2.76%	-10.50%	-11.72%	-18.45%	-70.88%

Valuation

CSV

Market cap₹2,169 Cr

P/E (TTM)72.8

EPS (TTM)0.46

Shares outstanding65.45Cr

Listed10 Jul 2025

Ownership

CSV

Promoter—

Promoter Δ QoQ—

Public—

FII—

DII—

Pledged—

Quarterly results · consolidated

CSV

	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue (₹ Cr)	86.3	101.1	97.7	81.9
YoY chg	—	—	—	+249.4%
Net profit (₹ Cr)	13.9	19.2	(7.1)	3.8
YoY chg	—	—	—	-24.3%
Net margin	16.1%	19.0%	-7.3%	4.6%
EPS	2.11	0.29	0.10	0.05

Shareholding over time

CSV

By quarter

17 Aug 2026 · promoter 63.08% · public 36.92%

2025-062026-08

Promoter
Public and others

Promoter: 63.08%
Public: 36.92%
Promoter change: +0.93 pp
Filed: 21 Aug 2026

FII: 5.57%
DII: 1.26%
Promoter pledged: 6.81%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV

₹ crore, as filed

	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26^A	Q1 FY27
Revenue from operations	23.4	86.3	101.1	97.7	81.9
Other income	7.5	2.5	1.1	1.3	1.5
Total income	30.9	88.8	102.2	99.0	83.4
Total expenses	20.6	71.5	80.9	101.3	75.6
└ Finance costs	0.7	0.9	0.6	3.6	3.5
└ Depreciation	0.8	0.5	0.8	0.9	1.4
Profit before tax	10.3	17.3	21.2	(2.3)	7.8
Tax expense	5.2	3.4	2.0	4.9	4.0
Net profit	5.0	13.9	19.2	(7.1)	3.8
EPS	0.08	2.15	0.30	-0.11	0.06
Net margin	21.36%	16.10%	19.03%	-7.28%	4.63%
PBT margin	43.88%	20.05%	21.02%	-2.31%	9.56%
Tax rate	50.23%	19.45%	9.20%	—	51.59%

^A audited · ^R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 14 Aug 2026.

FISCHER at a glance

FISCHER closed at ₹33.14 on 6 Oct 2026, +1.04% on the day, -70.9% over one year, 72.8% below its 52-week high of ₹121.7.
Delivery was 56.2% of traded quantity on 6 Oct 2026, the 80th percentile of its own 307 sessions with a reading (20-session average 58.2%, 1-year average 41.1%).
Market capitalisation is ₹2,169 crore at a trailing P/E of 72.8 (trailing EPS ₹0.46).
Q1 FY27 results (consolidated, filed 14 Aug 2026): revenue ₹82 crore (+249.4% year on year), net profit ₹4 crore (-24.3%); the price moved -3.5% on the first session after.
Promoters held 63.08% at 17 Aug 2026, up 0.93 percentage points on the previous filing, with 6.81% of promoter shares pledged.
Q2 FY27 results are expected between 29 Oct 2026 and 30 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV

Macro sectorHealthcare

Basic industryMedical Equipment & Supplies

ISININE771F01041

SeriesEQ

Listed10 Jul 2025

History from10 Jul 2025

Sessions307

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Healthcare Equipment & Supplies

CSV

All Healthcare Equipment & Supplies stocks on the NSE All Healthcare stocks on the NSE